The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...

For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving ...

The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have ...

AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings ...

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

Tiny Health's Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...

The question is whether these AI tools will be another fragmented layer of technology or true assistants to help them spend ...

Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...

While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: ...